Literature DB >> 21556978

Silicate and borate glasses as composite fillers: a bioactivity and biocompatibility study.

P P Lopes1, B J M Leite Ferreira, P S Gomes, R N Correia, M H Fernandes, M H V Fernandes.   

Abstract

Composites filled with a silicate glass (CSi) and a new borate glass (CB) were developed and compared in terms of their in vitro behaviour both in acellular and cellular media. Acellular tests were carried out in SBF and the composites were characterized by SEM-EDS, XRD and ICP. Biocompatibility studies were investigated by in vitro cell culture with MG-63 osteoblast-like and human bone marrow cells. The growth of spherical calcium phosphate aggregates was observed in acellular medium on all composite surfaces indicating that these materials became potentially bioactive. The biological assessment resulted in a dissimilar behavior of the composites. The CSi demonstrated an inductive effect on the proliferation of cells. The cells showed a normal morphology and high growth rate when compared to standard culture plates. Contrarily, inhibition of cell proliferation occurred in the CB probably due to its high degradation rate, leading to high B and Mg ionic concentration in the cell culture medium.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21556978     DOI: 10.1007/s10856-011-4331-6

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  24 in total

1.  Effects of Si speciation on the in vitro bioactivity of glasses.

Authors:  J M Oliveira; R N Correia; M H Fernandes
Journal:  Biomaterials       Date:  2002-01       Impact factor: 12.479

2.  Cellular responses to whitlockite.

Authors:  L M Ryan; H S Cheung; R Z LeGeros; I V Kurup; J Toth; P R Westfall; G M McCarthy
Journal:  Calcif Tissue Int       Date:  1999-11       Impact factor: 4.333

3.  Interfacial phenomena: an in vitro study of the effect of calcium phosphate (Ca-P) ceramic on bone formation.

Authors:  J E Hulshoff; K van Dijk; J E de Ruijter; F J Rietveld; L A Ginsel; J A Jansen
Journal:  J Biomed Mater Res       Date:  1998-06-05

4.  The silicon content of body fluids.

Authors:  J W Dobbie; M J Smith
Journal:  Scott Med J       Date:  1982-01       Impact factor: 0.729

5.  Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, beta-glycerophosphate and dexamethasone on osteoblastic differentiation.

Authors:  M J Coelho; M H Fernandes
Journal:  Biomaterials       Date:  2000-06       Impact factor: 12.479

6.  Human bone cell cultures in biocompatibility testing. Part I: osteoblastic differentiation of serially passaged human bone marrow cells cultured in alpha-MEM and in DMEM.

Authors:  M J Coelho; A T Cabral; M H Fernande
Journal:  Biomaterials       Date:  2000-06       Impact factor: 12.479

7.  Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype?

Authors:  J Clover; M Gowen
Journal:  Bone       Date:  1994 Nov-Dec       Impact factor: 4.398

Review 8.  Novel bioactive materials with different mechanical properties.

Authors:  Tadashi Kokubo; Hyun-Min Kim; Masakazu Kawashita
Journal:  Biomaterials       Date:  2003-06       Impact factor: 12.479

9.  Effect of borate glass composition on its conversion to hydroxyapatite and on the proliferation of MC3T3-E1 cells.

Authors:  Roger F Brown; Mohamed N Rahaman; Agatha B Dwilewicz; Wenhai Huang; Delbert E Day; Yadong Li; B Sonny Bal
Journal:  J Biomed Mater Res A       Date:  2009-02       Impact factor: 4.396

10.  Kinetics and mechanisms of the conversion of silicate (45S5), borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solutions.

Authors:  Wenhai Huang; Delbert E Day; Kanisa Kittiratanapiboon; Mohamed N Rahaman
Journal:  J Mater Sci Mater Med       Date:  2006-07       Impact factor: 4.727

View more
  1 in total

1.  Influence of ibuprofen addition on the properties of a bioactive bone cement.

Authors:  P P Lopes; M S Silva; M H V Fernandes
Journal:  J Mater Sci Mater Med       Date:  2013-05-16       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.